Ketoacidosis in Neonatal Diabetes Mellitus, Part of Wolcott-Rallison Syndrome

BACKGROUND Neonatal diabetes mellitus is a rare condition and it is important to differentiate it from other causes, such as hyperglycemia in infancy, for better outcomes. We report a case of an infant who presented to our neonatal intensive care unit in ketoacidosis and a comatose state. CASE REPOR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of case reports 2017-06, Vol.18, p.719-722
Hauptverfasser: Sreeramaneni, Poorna Gopal Azad, Ambula, Subba Rao V
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 722
container_issue
container_start_page 719
container_title The American journal of case reports
container_volume 18
creator Sreeramaneni, Poorna Gopal Azad
Ambula, Subba Rao V
description BACKGROUND Neonatal diabetes mellitus is a rare condition and it is important to differentiate it from other causes, such as hyperglycemia in infancy, for better outcomes. We report a case of an infant who presented to our neonatal intensive care unit in ketoacidosis and a comatose state. CASE REPORT Our case was an infant who presented to the neonatal intensive care unit at 38 days of age in ketoacidosis. The female infant, born to consanguineous parents (first cousins), weighing 2,300 grams at birth, presented with extreme dehydration and pale skin. The infant's head was normocephalic and there were no obvious deformities on the rest of her body. Urine examination was positive for ketones and glucose was 4+. Her blood glucose level was 550 mg/dL (30.5 mmol/L). After taking care of electrolytes, insulin was initiated in the form of a continuous drip. After a few days, insulin glargine was initiated, given twice daily via subcutaneous route. A few days later, blood samples were sent from our hospital in India to the UK and genetic testing was performed free of charge by the Department of Molecular Genetics, University of Exeter Medical School, UK, and confirmed a genetic diagnosis of Wolcott-Rallison syndrome. CONCLUSIONS Regardless of whether permanent neonatal diabetes mellitus is associated with Wolcott-Rallison syndrome or other genetic mutations, it is important to initially stabilize the infant and later do a genetic testing to see whether the infant can be given oral sulfonylureas or has to be given insulin therapy.
doi_str_mv 10.12659/AJCR.902804
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5499629</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1914290474</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-995f13083cf22b1f3fabd81f3c7f3e279f87e547127db066af666e705d9ffdd03</originalsourceid><addsrcrecordid>eNpVUclOwzAUtBCIotIbZ5Qjh6Z4ie34glSVnRZQAXG0nMQGoyQusYPUvyfQUpV3mSfNaN4yABwhOEKYUXE6vp3MRwLiFCY74ACJBMVUYLK71ffAwPsP2BXDjGOyD3o4ZRRTRg_A7E4Hp3JbOG99ZOvoXrtaBVVG51ZlOmgfzXRZ2tD6YfSomhA5E726MnchxHPVMd7V0dOyLhpX6UOwZ1Tp9WCNffByefE8uY6nD1c3k_E0zkmahFgIahCBKckNxhkyxKisSDvMuSEac2FSrmnCEeZFBhlThjGmOaSFMKYoIOmDs5Xvos0qXeS6Do0q5aKxlWqW0ikr_zO1fZdv7kvSRAiGRWdwsjZo3GerfZCV9Xl3qKq1a71EAiVYwIQnnXS4kuaN877RZjMGQfkbgvwJQa5C6OTH26ttxH8vJ98qBYMV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1914290474</pqid></control><display><type>article</type><title>Ketoacidosis in Neonatal Diabetes Mellitus, Part of Wolcott-Rallison Syndrome</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Sreeramaneni, Poorna Gopal Azad ; Ambula, Subba Rao V</creator><creatorcontrib>Sreeramaneni, Poorna Gopal Azad ; Ambula, Subba Rao V</creatorcontrib><description>BACKGROUND Neonatal diabetes mellitus is a rare condition and it is important to differentiate it from other causes, such as hyperglycemia in infancy, for better outcomes. We report a case of an infant who presented to our neonatal intensive care unit in ketoacidosis and a comatose state. CASE REPORT Our case was an infant who presented to the neonatal intensive care unit at 38 days of age in ketoacidosis. The female infant, born to consanguineous parents (first cousins), weighing 2,300 grams at birth, presented with extreme dehydration and pale skin. The infant's head was normocephalic and there were no obvious deformities on the rest of her body. Urine examination was positive for ketones and glucose was 4+. Her blood glucose level was 550 mg/dL (30.5 mmol/L). After taking care of electrolytes, insulin was initiated in the form of a continuous drip. After a few days, insulin glargine was initiated, given twice daily via subcutaneous route. A few days later, blood samples were sent from our hospital in India to the UK and genetic testing was performed free of charge by the Department of Molecular Genetics, University of Exeter Medical School, UK, and confirmed a genetic diagnosis of Wolcott-Rallison syndrome. CONCLUSIONS Regardless of whether permanent neonatal diabetes mellitus is associated with Wolcott-Rallison syndrome or other genetic mutations, it is important to initially stabilize the infant and later do a genetic testing to see whether the infant can be given oral sulfonylureas or has to be given insulin therapy.</description><identifier>ISSN: 1941-5923</identifier><identifier>EISSN: 1941-5923</identifier><identifier>DOI: 10.12659/AJCR.902804</identifier><identifier>PMID: 28652565</identifier><language>eng</language><publisher>United States: International Scientific Literature, Inc</publisher><subject>Adult ; Consanguinity ; Diabetes Mellitus, Type 1 - diagnosis ; Diabetes Mellitus, Type 1 - genetics ; Diabetic Ketoacidosis - etiology ; eIF-2 Kinase - genetics ; Epiphyses - abnormalities ; Female ; Genetic Testing ; Humans ; Infant, Newborn ; Mutation, Missense ; Osteochondrodysplasias - diagnosis ; Osteochondrodysplasias - genetics</subject><ispartof>The American journal of case reports, 2017-06, Vol.18, p.719-722</ispartof><rights>Am J Case Rep, 2017 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-995f13083cf22b1f3fabd81f3c7f3e279f87e547127db066af666e705d9ffdd03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499629/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499629/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28652565$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sreeramaneni, Poorna Gopal Azad</creatorcontrib><creatorcontrib>Ambula, Subba Rao V</creatorcontrib><title>Ketoacidosis in Neonatal Diabetes Mellitus, Part of Wolcott-Rallison Syndrome</title><title>The American journal of case reports</title><addtitle>Am J Case Rep</addtitle><description>BACKGROUND Neonatal diabetes mellitus is a rare condition and it is important to differentiate it from other causes, such as hyperglycemia in infancy, for better outcomes. We report a case of an infant who presented to our neonatal intensive care unit in ketoacidosis and a comatose state. CASE REPORT Our case was an infant who presented to the neonatal intensive care unit at 38 days of age in ketoacidosis. The female infant, born to consanguineous parents (first cousins), weighing 2,300 grams at birth, presented with extreme dehydration and pale skin. The infant's head was normocephalic and there were no obvious deformities on the rest of her body. Urine examination was positive for ketones and glucose was 4+. Her blood glucose level was 550 mg/dL (30.5 mmol/L). After taking care of electrolytes, insulin was initiated in the form of a continuous drip. After a few days, insulin glargine was initiated, given twice daily via subcutaneous route. A few days later, blood samples were sent from our hospital in India to the UK and genetic testing was performed free of charge by the Department of Molecular Genetics, University of Exeter Medical School, UK, and confirmed a genetic diagnosis of Wolcott-Rallison syndrome. CONCLUSIONS Regardless of whether permanent neonatal diabetes mellitus is associated with Wolcott-Rallison syndrome or other genetic mutations, it is important to initially stabilize the infant and later do a genetic testing to see whether the infant can be given oral sulfonylureas or has to be given insulin therapy.</description><subject>Adult</subject><subject>Consanguinity</subject><subject>Diabetes Mellitus, Type 1 - diagnosis</subject><subject>Diabetes Mellitus, Type 1 - genetics</subject><subject>Diabetic Ketoacidosis - etiology</subject><subject>eIF-2 Kinase - genetics</subject><subject>Epiphyses - abnormalities</subject><subject>Female</subject><subject>Genetic Testing</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Mutation, Missense</subject><subject>Osteochondrodysplasias - diagnosis</subject><subject>Osteochondrodysplasias - genetics</subject><issn>1941-5923</issn><issn>1941-5923</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUclOwzAUtBCIotIbZ5Qjh6Z4ie34glSVnRZQAXG0nMQGoyQusYPUvyfQUpV3mSfNaN4yABwhOEKYUXE6vp3MRwLiFCY74ACJBMVUYLK71ffAwPsP2BXDjGOyD3o4ZRRTRg_A7E4Hp3JbOG99ZOvoXrtaBVVG51ZlOmgfzXRZ2tD6YfSomhA5E726MnchxHPVMd7V0dOyLhpX6UOwZ1Tp9WCNffByefE8uY6nD1c3k_E0zkmahFgIahCBKckNxhkyxKisSDvMuSEac2FSrmnCEeZFBhlThjGmOaSFMKYoIOmDs5Xvos0qXeS6Do0q5aKxlWqW0ikr_zO1fZdv7kvSRAiGRWdwsjZo3GerfZCV9Xl3qKq1a71EAiVYwIQnnXS4kuaN877RZjMGQfkbgvwJQa5C6OTH26ttxH8vJ98qBYMV</recordid><startdate>20170627</startdate><enddate>20170627</enddate><creator>Sreeramaneni, Poorna Gopal Azad</creator><creator>Ambula, Subba Rao V</creator><general>International Scientific Literature, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170627</creationdate><title>Ketoacidosis in Neonatal Diabetes Mellitus, Part of Wolcott-Rallison Syndrome</title><author>Sreeramaneni, Poorna Gopal Azad ; Ambula, Subba Rao V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-995f13083cf22b1f3fabd81f3c7f3e279f87e547127db066af666e705d9ffdd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Consanguinity</topic><topic>Diabetes Mellitus, Type 1 - diagnosis</topic><topic>Diabetes Mellitus, Type 1 - genetics</topic><topic>Diabetic Ketoacidosis - etiology</topic><topic>eIF-2 Kinase - genetics</topic><topic>Epiphyses - abnormalities</topic><topic>Female</topic><topic>Genetic Testing</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Mutation, Missense</topic><topic>Osteochondrodysplasias - diagnosis</topic><topic>Osteochondrodysplasias - genetics</topic><toplevel>online_resources</toplevel><creatorcontrib>Sreeramaneni, Poorna Gopal Azad</creatorcontrib><creatorcontrib>Ambula, Subba Rao V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sreeramaneni, Poorna Gopal Azad</au><au>Ambula, Subba Rao V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ketoacidosis in Neonatal Diabetes Mellitus, Part of Wolcott-Rallison Syndrome</atitle><jtitle>The American journal of case reports</jtitle><addtitle>Am J Case Rep</addtitle><date>2017-06-27</date><risdate>2017</risdate><volume>18</volume><spage>719</spage><epage>722</epage><pages>719-722</pages><issn>1941-5923</issn><eissn>1941-5923</eissn><abstract>BACKGROUND Neonatal diabetes mellitus is a rare condition and it is important to differentiate it from other causes, such as hyperglycemia in infancy, for better outcomes. We report a case of an infant who presented to our neonatal intensive care unit in ketoacidosis and a comatose state. CASE REPORT Our case was an infant who presented to the neonatal intensive care unit at 38 days of age in ketoacidosis. The female infant, born to consanguineous parents (first cousins), weighing 2,300 grams at birth, presented with extreme dehydration and pale skin. The infant's head was normocephalic and there were no obvious deformities on the rest of her body. Urine examination was positive for ketones and glucose was 4+. Her blood glucose level was 550 mg/dL (30.5 mmol/L). After taking care of electrolytes, insulin was initiated in the form of a continuous drip. After a few days, insulin glargine was initiated, given twice daily via subcutaneous route. A few days later, blood samples were sent from our hospital in India to the UK and genetic testing was performed free of charge by the Department of Molecular Genetics, University of Exeter Medical School, UK, and confirmed a genetic diagnosis of Wolcott-Rallison syndrome. CONCLUSIONS Regardless of whether permanent neonatal diabetes mellitus is associated with Wolcott-Rallison syndrome or other genetic mutations, it is important to initially stabilize the infant and later do a genetic testing to see whether the infant can be given oral sulfonylureas or has to be given insulin therapy.</abstract><cop>United States</cop><pub>International Scientific Literature, Inc</pub><pmid>28652565</pmid><doi>10.12659/AJCR.902804</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1941-5923
ispartof The American journal of case reports, 2017-06, Vol.18, p.719-722
issn 1941-5923
1941-5923
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5499629
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Consanguinity
Diabetes Mellitus, Type 1 - diagnosis
Diabetes Mellitus, Type 1 - genetics
Diabetic Ketoacidosis - etiology
eIF-2 Kinase - genetics
Epiphyses - abnormalities
Female
Genetic Testing
Humans
Infant, Newborn
Mutation, Missense
Osteochondrodysplasias - diagnosis
Osteochondrodysplasias - genetics
title Ketoacidosis in Neonatal Diabetes Mellitus, Part of Wolcott-Rallison Syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A29%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ketoacidosis%20in%20Neonatal%20Diabetes%20Mellitus,%20Part%20of%20Wolcott-Rallison%20Syndrome&rft.jtitle=The%20American%20journal%20of%20case%20reports&rft.au=Sreeramaneni,%20Poorna%20Gopal%20Azad&rft.date=2017-06-27&rft.volume=18&rft.spage=719&rft.epage=722&rft.pages=719-722&rft.issn=1941-5923&rft.eissn=1941-5923&rft_id=info:doi/10.12659/AJCR.902804&rft_dat=%3Cproquest_pubme%3E1914290474%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1914290474&rft_id=info:pmid/28652565&rfr_iscdi=true